Influence of mutations associated with Gilbert and Crigler–Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates-Reference-Cited by-同舟云学术

Influence of mutations associated with Gilbert and Crigler–Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates

Published:2007-12 Issue:12 Volume:17 Page:1017-1029
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Udomuksorn Wandee,Elliot David J.,Lewis Benjamin C.,Mackenzie Peter I.,Yoovathaworn Krongtong,Miners John O.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference44 articles.

1. Drug glucuronidation in humans;Miners;Pharmacol Ther,1991

2. Structural and functional studies of UDP-glucuronosyltransferases;Radominska-Pandaya;Drug Metab Rev,1999

3. Human UDP-glucuronosyltransferase: metabolism, expression, and disease;Tukey;Annu Rev Pharmacol Toxicol,2000

4. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily;Mackenzie;Pharmacogenet Genom,2005

5. Predicting human drug glucuronidation parameters: application of in-vitro and in-silico modeling approaches;Miners;Annu Rev Pharmacol Toxicol,2004

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UDP-Glycosyltransferases;Reference Module in Biomedical Sciences;2024

2. Phase II metabolic transformations;An Integrated Guide to Human Drug Metabolism;2024

3. Biotransformation;Patty's Toxicology;2023-12-19

4. Impact of Pharmacogenomics in Clinical Practice;Pharmaceuticals;2023-11-13

5. A Rare Case of Primary Sjogren’s Syndrome Coexisting With Gilbert Syndrome;Cureus;2023-09-19